[DAYTON, Ohio, US and LONG CRENDON, Buckinghamshire, UK] – CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe’s passive product portfolio.

“Through this combination, we will be the partner of choice for cold chain delivery of high value, temperature sensitive pharmaceutical therapies. Both CSafe and Softbox have proven to be reliable partners for customers seeking a secure way to deliver their life-enhancing products around the world,” said Patrick Schafer, CSafe CEO. “We’re thrilled to now offer our customers a platform that provides everything from the highest quality packaging to AI-enabled thermal and kinetic monitoring and logistics management.”

“Our businesses are each rooted in a commitment to excellent customer service and high product quality, which made this combination a natural fit,” said Kevin Valentine, CEO of Softbox. “Together we will proudly continue to partner with our global Pharmaceutical customers to devise and deliver the best solutions for their evolving cold chain shipping needs, supporting the delivery of temperature sensitive lifesaving medicines and vaccines.

Together, they will provide the most comprehensive suite of thermal shipping solutions and become a one-stop-shop for all pharmaceutical cold chain shipping needs, enabling delivery of critical temperature-sensitive products, including next generation biologics, cell and gene therapy, and mRNA therapies such as the COVID-19 vaccine.

The acquisition will unlock opportunities for innovation as well as enhance CSafe’s sustainable and eco-friendly offerings, with new reusable and recyclable pallet and parcel solutions.